Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |